Hetlioz: payments to doctors
Payments that named Hetlioz as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $2.8M
- Providers
- 23,869
- Transactions
- 127,588
- Average per transaction
- $22
The per-transaction average — $22 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 23,869 providers the average total is $118, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Vanda Pharmaceuticals Inc. | $2,819,464 | 100.0% |